{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:27:54Z","timestamp":1794137274887,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"DOI":"10.1186\/s42466-025-00431-x","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:16:42Z","timestamp":1762967802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ketogenic diet for status epilepticus in adult intensive care unit patients: a standard operating procedure"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-712X","authenticated-orcid":false,"given":"Katharina","family":"Feil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schweikert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Adolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Kindzierski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Single","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"B\u00f6sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annerose","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"10","key":"431_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka, E., et al. (2015). A definition and classification of status epilepticus\u2013Report of the ILAE task force on classification of status epilepticus. Epilepsia, 56(10), 1515\u20131523.","journal-title":"Epilepsia"},{"issue":"2","key":"431_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/CON.0000000000001103","volume":"28","author":"E Trinka","year":"2022","unstructured":"Trinka, E., & Leitinger, M. (2022). Management of status epilepticus, refractory status epilepticus, and Super-refractory status epilepticus. Continuum (Minneap Minn), 28(2), 559\u2013602.","journal-title":"Continuum (Minneap Minn)"},{"key":"431_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","volume":"49","author":"AM Kantanen","year":"2015","unstructured":"Kantanen, A. M., et al. (2015). Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy & Behavior, 49, 131\u2013134.","journal-title":"Epilepsy & Behavior"},{"issue":"6","key":"431_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/s-0040-1718722","volume":"40","author":"EL Johnson","year":"2020","unstructured":"Johnson, E. L., & Kaplan, P. W. (2020). Status epilepticus: Definition, Classification, Pathophysiology, and epidemiology. Seminars in Neurology, 40(6), 647\u2013651.","journal-title":"Seminars in Neurology"},{"issue":"6","key":"431_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/epi.17982","volume":"65","author":"L Vignatelli","year":"2024","unstructured":"Vignatelli, L., et al. (2024). Clinical practice guidelines on the management of status epilepticus in adults: A systematic review. Epilepsia, 65(6), 1512\u20131530.","journal-title":"Epilepsia"},{"key":"431_CR6","doi-asserted-by":"crossref","unstructured":"Katz, J. B. (2021). Pearls and pitfalls of introducing ketogenic diet in adult status epilepticus: A practical guide for the intensivist. J Clin Med, 10(4).","DOI":"10.3390\/jcm10040881"},{"issue":"5","key":"431_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1212\/CPJ.0000000000001009","volume":"11","author":"N Kaul","year":"2021","unstructured":"Kaul, N., et al. (2021). Practical considerations for ketogenic diet in adults with Super-Refractory status epilepticus. Neurol Clin Pract, 11(5), 438\u2013444.","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"431_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s42466-023-00261-9","volume":"5","author":"K Bauer","year":"2023","unstructured":"Bauer, K., et al. (2023). Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes. Neurol Res Pract, 5(1), 34.","journal-title":"Neurol Res Pract"},{"issue":"1","key":"431_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42466-024-00322-7","volume":"6","author":"A Adhikari","year":"2024","unstructured":"Adhikari, A., et al. (2024). Use of ketamine in super refractory status epilepticus: A systematic review. Neurol Res Pract, 6(1), 33.","journal-title":"Neurol Res Pract"},{"issue":"1","key":"431_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s42466-024-00348-x","volume":"6","author":"L M\u00f6ller","year":"2024","unstructured":"M\u00f6ller, L., et al. (2024). Stiripentol for the treatment of refractory status epilepticus. Neurol Res Pract, 6(1), 49.","journal-title":"Neurol Res Pract"},{"issue":"3","key":"431_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/epi4.12924","volume":"9","author":"R Jha","year":"2024","unstructured":"Jha, R., et al. (2024). Surgical management of status epilepticus: A systematic review. Epilepsia Open, 9(3), 850\u2013864.","journal-title":"Epilepsia Open"},{"issue":"1","key":"431_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","volume":"48","author":"KJ Bough","year":"2007","unstructured":"Bough, K. J., & Rho, J. M. (2007). Anticonvulsant mechanisms of the ketogenic diet. Epilepsia, 48(1), 43\u201358.","journal-title":"Epilepsia"},{"key":"431_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.seizure.2022.01.019","volume":"96","author":"S Chomtho","year":"2022","unstructured":"Chomtho, S., Uaariyapanichkul, J., & Chomtho, K. (2022). Outcomes of parenteral vs enteral ketogenic diet in pediatric super-refractory status epilepticus. Seizure, 96, 79\u201385.","journal-title":"Seizure"},{"issue":"3","key":"431_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bj.2020.02.002","volume":"43","author":"KL Lin","year":"2020","unstructured":"Lin, K. L., Lin, J. J., & Wang, H. S. (2020). Application of ketogenic diets for pediatric neurocritical care. Biomed J, 43(3), 218\u2013225.","journal-title":"Biomed J"},{"key":"431_CR15","doi-asserted-by":"crossref","unstructured":"Wells, J. (2020). Efficacy and safety of a ketogenic diet in children and adolescents with refractory Epilepsy-A review. Nutrients, 12(6).","DOI":"10.3390\/nu12061809"},{"issue":"10","key":"431_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/WNL.0000000000003690","volume":"88","author":"MC Cervenka","year":"2017","unstructured":"Cervenka, M. C., et al. (2017). Phase I\/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology, 88(10), 938\u2013943.","journal-title":"Neurology"},{"issue":"3","key":"431_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12028-018-0653-2","volume":"30","author":"BA Francis","year":"2019","unstructured":"Francis, B. A., et al. (2019). The Feasibility, safety and effectiveness of a ketogenic diet for refractory status epilepticus in adults in the intensive care unit. Neurocritical Care, 30(3), 652\u2013657.","journal-title":"Neurocritical Care"},{"key":"431_CR18","doi-asserted-by":"publisher","first-page":"1517850","DOI":"10.3389\/fneur.2024.1517850","volume":"15","author":"Y Ren","year":"2024","unstructured":"Ren, Y., et al. (2024). Ketogenic diet treatment for super-refractory status epilepticus in the intensive care unit: feasibility, safety and effectiveness. Frontiers in Neurology, 15, 1517850.","journal-title":"Frontiers in Neurology"},{"issue":"8","key":"431_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0000000000000151","volume":"82","author":"KT Thakur","year":"2014","unstructured":"Thakur, K. T., et al. (2014). Ketogenic diet for adults in super-refractory status epilepticus. Neurology, 82(8), 665\u2013670.","journal-title":"Neurology"},{"issue":"5","key":"431_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.braindev.2018.12.007","volume":"41","author":"EG Park","year":"2019","unstructured":"Park, E. G., Lee, J., & Lee, J. (2019). The ketogenic diet for super-refractory status epilepticus patients in intensive care units. Brain Development, 41(5), 420\u2013427.","journal-title":"Brain Development"},{"issue":"9","key":"431_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamaneurol.2023.2407","volume":"80","author":"CD Cornwall","year":"2023","unstructured":"Cornwall, C. D., et al. (2023). Outcomes and treatment approaches for Super-Refractory status epilepticus: A systematic review and Meta-Analysis. JAMA Neurol, 80(9), 959\u2013968.","journal-title":"JAMA Neurol"},{"issue":"1","key":"431_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.seizure.2009.10.009","volume":"19","author":"R van Delft","year":"2010","unstructured":"van Delft, R., et al. (2010). Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine. Seizure, 19(1), 36\u201339.","journal-title":"Seizure"},{"issue":"11","key":"431_CR23","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1111\/epi.17397","volume":"63","author":"R Wickstrom","year":"2022","unstructured":"Wickstrom, R., et al. (2022). International consensus recommendations for management of new onset refractory status epilepticus (NORSE) incl. Febrile Infection-Related epilepsy syndrome (FIRES): Statements and supporting evidence. Epilepsia, 63(11), 2840\u20132864.","journal-title":"Epilepsia"},{"issue":"2","key":"431_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","volume":"3","author":"EH Kossoff","year":"2018","unstructured":"Kossoff, E. H., et al. (2018). Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the international ketogenic diet study group. Epilepsia Open, 3(2), 175\u2013192.","journal-title":"Epilepsia Open"},{"issue":"11","key":"431_CR25","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/j.1528-1167.2005.00282.x","volume":"46","author":"AG Bergqvist","year":"2005","unstructured":"Bergqvist, A. G., et al. (2005). Fasting versus gradual initiation of the ketogenic diet: A prospective, randomized clinical trial of efficacy. Epilepsia, 46(11), 1810\u20131819.","journal-title":"Epilepsia"},{"issue":"9","key":"431_CR26","first-page":"999","volume":"145","author":"G Opala","year":"1991","unstructured":"Opala, G., et al. (1991). The effect of valproic acid on plasma carnitine levels. American Journal of Diseases of Children, 145(9), 999\u20131001.","journal-title":"American Journal of Diseases of Children"},{"key":"431_CR27","doi-asserted-by":"publisher","first-page":"109279","DOI":"10.1016\/j.yebeh.2023.109279","volume":"144","author":"FJP Teixeira","year":"2023","unstructured":"Teixeira, F. J. P., et al. (2023). Utilization of the ketogenic diet for adults with status epilepticus. Epilepsy & Behavior, 144, 109279.","journal-title":"Epilepsy & Behavior"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-025-00431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-025-00431-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-025-00431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:44:03Z","timestamp":1788965043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-025-00431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1186\/s42466-025-00431-x","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KF received grants from the university of T\u00fcbingen (AKF and Sigrid-\u00d6rgel Stiftung) and speakers\u2019 honoraria\/consulting fees from AstraZeneca and BMS\/Pfizer, all not related to this work. DS, MA, SK, and CS report no conflict of interest. FB received speakers\u2019 honoraria\/consulting fees from Nutricia, Jazz Pharmaceuticals, UCB, Angelini Pharma, all not related to this work. JB received speaker honoraria and travel support from Boehringer, Medtronic, Neuroptics, TelaDoc; Award participation in PCORI Award for SETPOINT2 all not related to this work. AM received grants from the university of T\u00fcbingen (AKF) and speakers\u2019 honoraria\/consulting fees from AMGEN, all not related to this work.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We hereby confirm that all authors have read the submitted manuscript in its entirety and consent to its publication.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"87"}}